NYSE MKT LLC · NNVC
+1.43% · +$0.0200 · Vol 696.9K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
NanoViricides, Inc

NanoViricides, Inc

Biotechnology
$1.42
Card
Relationship Map

Follow $NNVC

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $NNVC by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
NNVC
NanoViricides, Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

81/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NNVC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NNVC catalysts
About NanoViricides, Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2005
Employees
7
Country
US

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.40
Day high
$1.48
Day low
$1.36
Previous close
$1.40
52W high
$2.03
-30.05% from high
52W low
$0.8500
48% of range
Market cap
$36.2M
EPS
$-0.4400
Beta
2.10
Shares out
25.5M
Volume
696.9K
1.66× rel vol
Avg volume
421.1K
VWAP
$1.42
Price history computed in-house
1W
+39.22%
1M
+6.77%
3M
+7.58%
1Y
-3.40%
YTD
+25.66%
SMA 50 $1.38 · above
SMA 200 $1.26 · above
52W position 48%

NNVC overview

Veridion Score
81
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around NNVC.Congress disclosuresOpen receipt and filing context for NNVC.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading NNVC Form 4 filings
Public disclosures

Congress activity in NNVC

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for NNVC in the cached public ledger.

Federal contracts

NNVC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NNVC in this window.
Lobbying spend

NNVC lobbying filings, year to date.

Registered lobbying filings matched to NanoViricides, Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NNVC in this window.
Loading news for NNVC
Analyst ratings
Sovereign unlock shows live analyst consensus for NNVC.
Options
Sovereign unlock shows live options positioning for NNVC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.